These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8977702)

  • 41. Pulse intravenous cyclophosphamide therapy in pemphigus.
    Fleischli ME; Valek RH; Pandya AG
    Arch Dermatol; 1999 Jan; 135(1):57-61. PubMed ID: 9923782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapy of pemphigus. Critical remarks based on 44 clinical cases].
    Smolle J
    Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
    Lever WF; Schaumburg-Lever G
    Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple autoimmune syndrome in a patient with pemphigus vulgaris.
    Grandhe NP; Dogra S; Kanwar AJ
    Acta Derm Venereol; 2005; 85(1):91-2. PubMed ID: 15849009
    [No Abstract]   [Full Text] [Related]  

  • 45. Localized CO
    Chainani-Wu N; Gopal-Murthy V; Wu A; Marinkovich MP
    Clin Adv Periodontics; 2023 Mar; 13(1):38-41. PubMed ID: 35649436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current therapy of the pemphigus group.
    Kasperkiewicz M; Schmidt E; Zillikens D
    Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Verrucous variant of pemphigus foliaceus.
    Ohashi T; Ohtsuka M; Kikuchi N; Yamamoto T
    Clin Exp Dermatol; 2020 Jul; 45(5):584-585. PubMed ID: 31725926
    [No Abstract]   [Full Text] [Related]  

  • 48. Cutaneous Mucormycosis: A Fatal Complication of Immunosuppressant Therapy for Pemphigus Vulgaris.
    Sahni K; De D; Dogra S; Kanwar A; Saikia UN
    Skinmed; 2017; 15(6):467-469. PubMed ID: 29282189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Localized pemphigus].
    Kharfi M; Fazaa B; Benmously R; Bouden S; Elloumi L; Kamoun MR
    Ann Dermatol Venereol; 2003; 130(6-7):645-7. PubMed ID: 13679705
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nail manifestations in pemphigus vulgaris.
    Cahali JB; Kakuda EY; Santi CG; Maruta CW
    Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(5):229-34. PubMed ID: 12436180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
    Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
    Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed Diagnosis of Pemphigus Vulgaris Initially Presenting as an Oral Ulcer: A Case Report.
    Lamichhane R; Chaudhary S
    JNMA J Nepal Med Assoc; 2022 Jul; 60(251):641-643. PubMed ID: 36705190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recalcitrant pemphigus successfully treated with lenalidomide.
    Zader J; Vucinic V; Simon JC; Treudler R
    Eur J Dermatol; 2020 Apr; 30(2):178-179. PubMed ID: 32538358
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
    Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
    Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
    [No Abstract]   [Full Text] [Related]  

  • 57. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S; Platamone A; Alaimo R; Bongiorno MR
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
    Sharma VK; Khandpur S
    Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
    Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
    J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cutaneous periarteritis nodosa resistant to combined corticosteroids and immunosuppressive agents. Efficacy of treatment with intravenous immunoglobulins].
    Machet L; Vincent O; Machet MC; Barruet K; Vaillant L; Lorette G
    Ann Dermatol Venereol; 1995; 122(11-12):769-72. PubMed ID: 8729821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.